ABEMACICLIB
Clinical trials for ABEMACICLIB explained in plain language.
Never miss a new study
Get alerted when new ABEMACICLIB trials appear
Sign up with your email to follow new studies for ABEMACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists seek to tame cancer Drug's harsh side effects
Disease control Not yet recruitingThis study aims to understand why a powerful breast cancer drug, abemaciclib, causes severe diarrhea and low white blood cell counts in many patients. Researchers will measure drug levels in the blood of 235 patients to see if these side effects are linked to how much of the drug…
Matched conditions: ABEMACICLIB
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Why do cancer patients quit Life-Saving drugs? new study investigates
Disease control Not yet recruitingThis study aims to understand why patients with early-stage, high-risk breast cancer stop taking their powerful new combination medications too soon. Researchers will follow 81 patients who are prescribed a standard hormone therapy pill plus a newer drug (like abemaciclib or ribo…
Matched conditions: ABEMACICLIB
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists hunt for gut clues to cancer Drug's nasty side effect
Knowledge-focused Not yet recruitingThis study aims to understand why many breast cancer patients experience severe diarrhea while taking the drug abemaciclib. Researchers will compare the gut bacteria of 60 patients who get diarrhea with those who don't, using stool and blood samples. The goal is to learn if the b…
Matched conditions: ABEMACICLIB
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC